Gemcitabine and docetaxel in metastatic breast cancer - further experience.

被引：0
|
作者：
Laufman, LR
Spiridonidis, CH
Boury, P
Parker, T
Glaub, E
Maggard, V
Miller, S
机构：
[1] Grant Med Ctr, Columbus, OH USA
[2] Grady Hosp, Delaware, OH USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [21] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PHTHJ
    Jong, PC
    Jong, RS
    Honkoop, AH
    Coenen, JLLM
    Rodenburg, CJ
    Rooda, SJE
    Douma, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
  • [22] Trastuzumab and docetaxel for metastatic breast cancer: An experience from a cancer centre in India
    Julka, PK
    Sharma, DN
    Mukhopadhyay, P
    Rath, GK
    CLINICAL ONCOLOGY, 2004, 16 (02) : 115 - 118
  • [23] Gemcitabine, docetaxel, and capecitabine (GTX) as a first-line regimen in metastatic pancreatic adenocarcinomas (mPAC): A single institution experience.
    Singh, Vikas
    Sharma, Vivek R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [24] Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancer
    Liljegren, Annelie
    Bergh, Jonas
    Castany, Roser
    BREAST, 2009, 18 (04): : 259 - 262
  • [25] Cabazitaxel in docetaxel-pretreated metastatic castration resistant prostate cancer (mCRPC): Canadian experience.
    Sridhar, Srikala S.
    Winquist, Eric
    Hubay, Stacey
    Assi, Hazem
    Berry, Scott R.
    Stewart, John
    Levesque, Eric
    Aucoin, Nathalie
    Czaykowski, Piotr
    Saad, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer
    E. Kontopodis
    N. Kentepozidis
    Ch. Christophyllakis
    I. Boukovinas
    A. Kalykaki
    K. Kalbakis
    L. Vamvakas
    S. Agelaki
    A. Kotsakis
    N. Vardakis
    V. Georgoulias
    D. Mavroudis
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 153 - 160
  • [27] Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?
    Levy, C
    Fumoleau, P
    CANCER TREATMENT REVIEWS, 2005, 31 : S17 - S22
  • [28] Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer
    Kontopodis, E.
    Kentepozidis, N.
    Christophyllakis, Ch.
    Boukovinas, I.
    Kalykaki, A.
    Kalbakis, K.
    Vamvakas, L.
    Agelaki, S.
    Kotsakis, A.
    Vardakis, N.
    Georgoulias, V.
    Mavroudis, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 153 - 160
  • [29] Docetaxel weekly with metastatic breast cancer
    Twelves, Chris
    ONKOLOGIE, 2007, 30 (8-9): : 407 - 408
  • [30] Updates on gemcitabine on metastatic breast cancer
    Gligorov, Joseph
    Selle, Frderic
    Khalil, Ahmed
    Abbas, Faddi
    Namer, Moyse
    Lotz, Jean-Pierre
    BULLETIN DU CANCER, 2007, 94 : S90 - S94
12345